Treatment of metabolic syndrome with ankaflavin, a secondary metabolite isolated from the edible fungus Monascus spp.

Applied Microbiology and Biotechnology

Volumn 98, Issue 11, 2014, Pages 4853-4863

  Hsu, Wei Hsuan ^a   Pan, Tzu Ming ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Ankaflavin; Metabolic syndrome; Monascus; Nuclear factor (erythroid derived 2) like 2 (Nrf2); Selective peroxisome proliferator activated receptor modulators (SPPARMs)

Indexed keywords

CHEMICAL ACTIVATION; CYTOLOGY; METABOLITES;

ANKAFLAVIN; METABOLIC SYNDROMES; MONASCUS; NUCLEAR FACTORS; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR;

METABOLISM;

ANKAFLAVIN; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; ANTIOXIDANT; APOLIPOPROTEIN A1; CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LIVER X RECEPTOR ALPHA; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; TRANSCRIPTION FACTOR NRF2; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; PIGMENT; RIBOFLAVIN DERIVATIVE;

EDIBLE SPECIES; FERMENTATION; FUNGUS; METABOLISM; SECONDARY METABOLITE; TRADITIONAL MEDICINE; TUMOR;

ANTIHYPERTENSIVE ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; CARBON NUCLEAR MAGNETIC RESONANCE; CHINESE MEDICINE; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DRUG ISOLATION; DRUG PURIFICATION; FUNGUS ISOLATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOMODULATION; METABOLIC SYNDROME X; MONASCUS; MONASCUS PURPUREUS; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PANCREAS FUNCTION; PROTON NUCLEAR MAGNETIC RESONANCE; SHORT SURVEY; THIN LAYER CHROMATOGRAPHY; TRIACYLGLYCEROL BLOOD LEVEL; AGONISTS; ANIMAL; CHEMISTRY; DISEASE MODEL; ISOLATION AND PURIFICATION; TREATMENT OUTCOME;

ASIA;

ANIMALS; DISEASE MODELS, ANIMAL; FLAVINS; METABOLIC SYNDROME X; MONASCUS; PIGMENTS, BIOLOGICAL; PPAR ALPHA; TREATMENT OUTCOME;

EID: 84901604322     PISSN: 01757598     EISSN: 14320614     Source Type: Journal    
DOI: 10.1007/s00253-014-5716-5     Document Type: Short Survey

References (88)

1. Adiels M, Taskinen MR, Packard C, Caslake MJ, Soro-Paavonen A (2006) Overproduction of large VLDL particles is driven by increased liver fat content in man. Diabetologia 49:755-765
2. Akihisa T, Tokuda H, Ukiya M, Kiyota A, Yasukawa K, Sakamoto N, Kimura Y, Suzuki T, Takayasu J, Nishino H (2005a) Anti-tumor initiating effects of monascin, an azaphilonoid pigment from the extract of Monascus pilosus fermented rice (red-mold rice). Chem Biodivers 2:1305-1309
3. Akihisa T, Tokuda H, Yasukawa K, Ukiya M, Kiyota A, Sakamoto N, Suzuki T, Tanabe N, Nishino H (2005b) Azaphilones, furanoisophthalides, and amino acids from the extracts of Monascus pilosus-fermented rice (red-mold rice) and their chemopreventive effects. J Agric Food Chem 53:562-565
4. Akiyama T, Sakai S, Lambert G, Nicol CJ, Matsusue K, Pimprale S, Lee YH, Ricote M, Glass CK, Brewer HBJ, Gonzalez FJ (2002) Conditional disruption of the peroxisome proliferator-activated receptor gamma gene in mice results in lowered expression of ABCA1, ABCG1, and apo E in macrophages and reduced cholesterol efflux. Mol Cell Biol 22:2607-2619
5. Bloemen K, Verstraelen S, van Den Heuvel R, Witters H, Nelissen I, Schoeters G (2007) The allergic cascade: review of the most important molecules in the asthmatic lung. Immunol Lett 113:6-18
6. Bonnefont-Rousselot D (2002) Glucose and reactive oxygen species. Curr Opin Clin Nutr Metab Care 5:561-568
7. Brissova M, Blaha M, Spear C (2005) Reduced PDX-1 expression impairs islet response to insulin resistance and worsens glucose homeostasis. Am J Physiol Endocrinol Metab 288:707-714
8. Carreon-Torres E, Rendon-Sauer K, Monter-Garrido M, Toledo-Ibelles P, Gamboa R, Menjivar M, Lopez-Marure R, Luc G, Fievet C, Cruz D, Vargas-Alarcon G, Perez-Mendez W (2009) Rosiglitazone modifies HDL structure and increases HDL-apo AI synthesis and catabolic rates. Clin Chim Acta 401:37-41
9. Chen YH, Lin SJ, Chen YL, Liu PL, Chen JW (2006) Anti-inflammatory effects of different drugs/agents with antioxidant property on endothelial expression of adhesion molecules. Cardiovasc Hematol Disord: Drug Targets 6:279-304
10. Chen MJ, Chen JJ, Wu MD, Yan PS, Yuan GF (2010) Isolation and structure determination of one new metabolite isolated from the red fermented rice of Monascus purpureus. Nat Prod Res 24:979-988
11. Chen WL, Chen YL, Chiang YM, Wang SG, Lee HM (2012) Fenofibrate lowers lipid accumulation in myotubes by modulating the PPARa/AMPK/FoxO1/ATGL pathway. Biochem Pharmacol 84:522-531
12. Chockalingam A (2008) World hypertension day and global awareness. Can J Cardiol 24:441-444
13. Choi HK, Willett WC, Stampfer MJ, Rimm E, Hu FB (2005) Dairy consumption and risk of type 2 diabetes mellitus in men: a prospective study. Arch Intern Med 165:997-1003
14. Day JF, Thorpe SR, Baynes JW (1979) Non-enzymatically glucosylated albumin: in vitro preparation and isolation from normal human serum. J Biol Chem 254:595-597
15. Deakin S, Leviev I, Guernier S, James RW (2003) Simvastain modulates expression of the PON1 gene and increases plasmaparaoxonase. Arterios Thromb Vasc Biol 23:2083-2089
16. Grefhorst A, Elzinga BM, Voshol PJ, Plosch T, Kok T, Bloks VW, van der Sluijs FH, Havekes LM, Romijn JA, Verkade HJ, Kuipers F (2002) Stimulation of lipogenesis by pharmacological activation of the liver X receptor leads to production of large, triglyceride-rich very low density lipopoprotein particles. J Biol Chem 277:34182-34190
17. Guha M, Bai W, Nadler JL, Natarajan R (2000) Molecular mechanisms of tumor necrosis factor-alpha gene expression in monocytic cells via hyperglycemia- induced oxidant stress-dependent and -independent pathways. J Biol Chem 275:17728-17739
18. Harmon AW, Harp JB (2001) Differential effects of flavonoids on 3 T3-L1 adipogenesis and lipolysis. Am J Physiol 280:807-813
19. Hayek T, Fuhrman B, Vaya J, Rosenblat M, Belinky P, Coleman R, Elis A, Aviram M (1997) Reduced progression of atherosclerosis in apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation. Vasc Biol 17:2744-2752
20. He M, Siow RC, Sugden D, Gao L, Cheng X, Mann GE (2011) Induction of HO-1 and redox signaling in endothelial cells by advanced glycation end products: a role for Nrf2 in vascular protection in diabetes. Nutr Metab Cardiovasc Dis 21:277-285
21. Higgins LS, DePaoli AM (2010) Selective peroxisome proliferator-activated receptor g (PPARg) modulation as a strategy for safer therapeutic PPARg activation. Am J Clin Nutr 91:267-272
22. Ho BY, Pan TM (2009) The Monascus metabolite monacolin K reduces tumor progression and metastasis of Lewis lung carcinoma cells. J Agric Food Chem 57:8258-8265
23. Ho BY, Wu YM, Hsu YW, Hsu LC, Kuo YH, Chang KJ, Pan TM (2010) Effects of Monascus-fermented rice extract on malignant cell-associated neovascularization and intravasation determined using the chicken embryo chorioallantoic membrane model. Integr Cancer Ther 9:204-212
24. Hong MY, Seeram NP, Zhang Y, Heber D (2008a) Anti-cancer effects of Chinese red yeast rice beyond monacolin K alone in colon cancer cells. J Nutr Biochem 19:448-458
25. Hong MY, Seeram NP, Zhang Y, Heber D (2008b) Chinese red yeast rice versus lovastatin effects on prostate cancer cells with and without androgen receptor overexpression. J Med Food 11:657-666
26. Hsu WH, Lee BH, Pan TM (2010a) Red mould dioscorea-induced G2/M arrest and apoptosis in human oral cancer cells. J Sci Food Agric 90:2709-2715
27. Hsu WH, Lee BH, Pan TM (2010b) Protection of Monascus-fermented dioscorea against DMBA-induced oral injury in hamster by anti-inflammatory and antioxidative potentials. J Agric Food Chem 58:6715-6720
28. Hsu LC, Hsu YW, Liang YH, Kuo YH, Pan TM (2011a) Anti-tumor and anti-inflammatory properties of ankaflavin and monaphilone A from Monascus purpureus NTU 568. J Agric Food Chem 59:1124-1130
29. Hsu WH, Lee BH, Pan TM (2011b) Effects of red mold dioscorea on oral carcinogenesis in DMBA-induced hamster animal model. Food Chem Toxicol 49:1292-1297
30. Hsu WH, Lee BH, Huang YC, Hsu YW, Pan TM (2012a) Ankaflavin, a novel Nrf-2 activator for attenuating allergic airway inflammation. Free Radic Biol Med 53:1643-1651
31. Hsu WH, Lee BH, Lu IJ, Pan TM (2012b) Ankaflavin and monascin regulate endothelial adhesion molecules and endothelial NO synthase (eNOS) expression induced by tumor necrosis factor-alpha in human umbilical vein endothelial cells (HUVECs). J Agric Food Chem 60:1666-1672
32. Hsu WH, Huang YC, Lee BH, Hsu YW, Pan TM (2013a) The improvements of ankaflavin isolated from Monascus-fermented products on dyslipidemia in high-fat diet-induced hamster. J Funct Food 5:434-443
33. Hsu WH, Liao TH, Lee BH, Hsu YW, Pan TM (2013b) Ankaflavin regulates adipocyte function and attenuates hyperglycemia caused by high-fat diet via PPAR-gamma activation. J Funct Foods 5:124-132
34. Hsu WH, Chen TH, Lee BH, Hsu YW, Pan TM (2014) Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice. Food Chem Toxicol 64:94-103
35. Hyka N, Dayer JM, Modoux C, Kohno T, Edwards CK, Roux-Lombard P, Burger D (2001) Apolipoprotein A-1 inhibits the production of interleukin-1b and tumor necrosis factor-alpha by blocking contact-mediated activation of monocytes by T lymphocytes. Blood 97:2381-2389
36. Ikarashi N, Toda T, Okaniwa T, Ito K, Ochiai W, Sugiyama K (2011) Anti-obesity and anti-diabetic effects of Acacia polyphenol in obese diabetic KKAy mice fed high-fat diet. Evid Based Complement Alternat Med 2011: Article952031.
37. Juslova P, Martinkova L, Kren V (1996) Secondary metabolites of the fungus Monascus: a review. J Ind Microbiol 16:163-170
38. Kalaany NY, Mangelsdorf DJ (2006) LXRs and FXR: the yin and yang of cholesterol and fat metabolism. Ann Rev Physiol 68:159-191
39. Kaneto H, Miyatsuka T, Kawamori D (2008) PDX-1 and MafA play a crucial role in pancreatic beta-cell differentiation and maintenance of mature beta-cell function. Endocr J 55:235-252
40. Karsenty J, Landrier JF, Rousseau-Ralliard D, Robbez-Masson V, Margotat A, Deprez P, Lechêne P, Grynberg A, Lairon D, Planells R, Gastaldi M (2013) Beneficial effects of omega-3 fatty acids on the consequences of a fructose diet are not mediated by PPAR delta or PGC1 alpha. Eur J Nutr 52:1865-1874
41. Kelley GL, Allan G, Azhar S (2004) High dietary fructose induces a hepatic stress response resulting in cholesterol and lipid dysregulation. Endocrinology 145:548-555
42. Kershaw EE, Schupp M, Guan HP, Gardner NP, Lazar MA, Flier JS (2007) PPAR-gamma regulates adipose triglyceride lipase in adipocytes in vitro and in vivo. Am J Physiol Endocrinol Metab 293:1736-1745
43. Kikuchi N, Ishii Y, Morishima Y, Yageta Y, Haraguchi N, Itoh K, Yamamoto M, Hizawa N (2010) Nrf2 protects against pulmonary fibrosis by regulating the lung oxidant level and Th1/Th2 balance. Respir Res 11:31
44. Kopelman PG (2000) Obesity as amedical problem. Nature 404:635-643
45. Korach-Andre M, Archer A, Gabbi C, Barros RP, Pedrelli M, Steffensen KR, Pettersson AT, Laurencikiene J, Parini P, Gustafsson JA (2011) Liver X receptors regulate de novo lipogenesis in a tissue-specific manner in C57BL/6 female mice. Am J Physiol Endocrinol Metab 301:210-222
46. Lee CL, Kung YH, Wu CL, Hsu YH, Pan TM (2010) Monascin and ankaflavin act as novel hypolipidemic and high density lipoprotein-cholesterol-raising agents in redmold dioscorea. JAgric Food Chem 58:9013-9019
47. Lee BH, Hsu WH, Liao TH, Pan TM (2011) The Monascus metabolite monascin against TNF-alpha-induced insulin resistance via suppressing PPAR-gamma phosphorylation in C2C12 myotubes. Food Chem Toxicol 49:2609-2617
48. Lee BH, Hsu WH, Chang YY, Kuo HF, Hsu YW, Pan TM (2012) Ankaflavin: a natural novel PPARgamma agonist upregulates Nrf2 to attenuate methylglyoxal-induced diabetes in vivo. Free Radic Biol Med 53:2008-2016
49. Li T, Boehme S, Kong B, Nilsson LM, Guo G, Ellis E, Chiang JY (2011a) Overexpression of cholesterol 7α-hydroxylase promotes hepatic bile acid synthesis and secretion and maintains cholesterol homeostasis. Hepatology 53:996-1006
50. Li Y, Xu S, Mihaylova MM, Zheng B, Hou X, Jiang B, Park O, Luo Z, Lefai E, Shyy JY, Gao B, Wierzbicki M, Verbeuren TJ, Shaw RJ, Cohen RA, Zang M (2011b) AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metab 13:376-388
51. Libby P (2002) Inflammation in atherosclerosis. Nature 420:868-874
52. Lin CC, Li TC, Lai MM (2005) Efficacy and safety of Monascus purpureus Went rice in subjects with hyperlipidemia. Eur J Endocrinol 153:679-686
53. Lin WY, Hsu WY, Hish CH, Pan TM (2007) Proteome changes in Caco-2 cells treated with Monascus-fermented red mold rice extract. J Agric Food Chem 55:8987-8994
54. Lin CP, Lin YL, Huang PH, Ysai HS, Chen YH (2011) Inhibition of endothelial adhesion molecule expression by Monascus purpureus-fermented rice metabolites, monacolin K, ankaflavin, and monascin. J Sci Food Agric 91:1751-1758
55. Ma J, Li Y, Ye Q, Li J, Hua Y, Ju D, Zhang D, Cooper R, Chang M (2000) Constituents of red yeast rice, a traditional Chinese food and medicine. J Agric Food Chem 48:5220-5225
56. Martinkova L, Patakova-Juzlova P, Kren V, Kucerova Z, Havlicek V, Olsovsky P, Hovorka O, Rihova B, Vesely D, Vesela D, Ulrichova J, Prikrylova V (1999) Biological activities of oligoketide pigments of Monascus purpureus. Food Addit Contam 16:15-24
57. Millar JS, Ikewaki K, Bloedon LT, Wolfe ML, Szapary PO, Rader DJ (2011) Effect of rosiglitazone on HDL metabolism in subjects with metabolic syndrome and low HDL. J Lipid Res 52:136-142
58. Millatt LJ, Bocher V, Fruchart JC, Staels B (2003) Liver X receptors and the control of cholesterol homeostasis: potential therapeutic targets for the treatment of atherosclerosis. Biochim Biophys Acta 1631:107-118
59. Miura Y, Chiba T, Tomita I, Koizumi H, Umeqaki K, Hara Y, Ikeda M, Tomita T (2001) Tea catechins prevent the development of atherosclerosis in apoprotein E-deficient mice. J Nutr 131:27-32
60. Mogilenko DA, Dizhe EB, Shavva VS, Lapikov IA, Orlov SV, Perevozchikov AP (2009) Role of the nuclear receptors HNF4alpha, PPAR-alpha and LXRs in the TNFalpha-mediated inhibition of human apolipoprotein A-I gene expression Hep G2 cells. Biochemistry 48:11950-11960
61. Moibi JA, Gupta D, Jetton TL, Peshavaria M, Desai R, Leahy JL (2007) Peroxisome proliferator-activated receptor-gamma regulates expression of PDX-1 and NKX6.1 in INS-1cells. Diabetes 56:88-95
62. Ohsumi J, Sakakibara S, Yamaguchi J, Miyadai K, Yoshioka S, Fujiwara T, Horikoshi H, Serizawa N (1994) Troglitazone prevents the inhibitory effects of inflammatory cytokines on insulin-induced adipocyte differentiation in 3 T3-L1 cells. Endocrinology 135:2279-2282
63. Park KS, Ciaraldi TP, Lindgren K, Abrams-Carter L, Mudaliar S, Nikoulina SE, Tufari SR, Veerkamp JH, Vidal-Puig A, Henry RR (1998) Troglitazone effects on gene expression in human skeletal muscle of type II diabetes involve upregulation of peroxisome proliferator-activated receptor-gamma. J Clin Endocrinol Metab 83:2830-2835
64. Pereira MA, Jacobs DR, Van Horn L, Slattery ML (2002) Dairy consumption, obesity, and the insulin resistance syndrome in young adults: the CARDIA Study. J Am Med Assoc 287:2081-2089
65. Puddu GM, Cravero E, Arnone G, Muscari A, Puddu P (2005) Molecular aspects of atherogenesis: new insights and unsolved questions. J Biomed Sci 12:839-853
66. Rangasamy T, Guo J, Mitzner WA, Roman J, Singh A, Fryer AD, Yamamoto M, Kensler TW, Tuder RM, Georas SN, Biswal S (2005) Disruption of Nrf2 enhances susceptibility to severe airway inflammation and asthma in mice. J Exp Med 202:47-59
67. Ross R (1999) Atherosclerosis: an inflammatory disease. N Engl J Med 340:115-126
68. Saha AK, Ruderman NB (2003) Malonyl-CoA and AMP-activated protein kinase: an expanding partnership. Mol Cell Biochem 253:65-70
69. Sanyal AJ (2002) AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 123:1705-1725
70. Schoonjans K, Peinado-Onsurbe J, Lefebvre AM, Heyman RA, Briggs M, Deeb S, Staels B, Auwerx J (1996) PPAR-alpha and PPAR-gamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene. EMBO J 15:5336-5348
71. Shaw RJ, Lamia KA, Vasquez D, Koo SH, Bardeesy N, Depinho A, Montminy M, Cantley LC (2005) The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 310:1642-1646
72. Shetty C, Balasubramani M, Capps N, Millest J, Ramachandran S (2007) Paradoxical HDL-C reduction during rosiglitazone and fibrate treatment. Diabetic Med 24:94-97
73. Staels B, Fruchart JC (2005) Therapeutic roles of peroxisome proliferator-activated receptor agonists. Diabetes 54:2460-2470
74. Su YC, Wang JJ, Lin TT, Pan TM (2003) Production of the secondary metabolites γ-aminobutyric acid and monacolin K by Monascus. J Ind Microbiol Biotechnol 30:41-46
75. Su NW, Lin YL, Lee MH, Ho CY (2005) Ankaflavin from Monascus-fermented red rice exhibits selective cytotoxic effect and induces cell death on Hep G2 cells. J Agric Food Chem 53:1949-1954
76. Szalkowski D, White-Carrington S, Berger J, Zhang B (1995) Antidiabetic thiazolidinediones block the inhibitory effect of tumor necrosis factor-alpha on differentiation, insulin-stimulated glucose uptake, and gene expression in 3 T3-L1 cells. Endocrinology 136:1474-1481
77. Tenenbaum A, Motro M, Fisman EZ (2005) Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons. Cardiovasc Diabetol 4:14
78. Thornalley PJ (1994) Methylglyoxal glyoxalases and the development to diabetic complications. Amino Acids 6:15-23
79. Viollet B, Guigas B, Leclerc J, Hebrard S, Lantier L, Mounier R, Andreelli F, Foretz M (2009) AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives. Acta Physiol 196:81-89
80. Walters DM, Cho HY, Kleeberger SR (2008) Oxidative stress and antioxidants in the pathogensis of pulmonary fibrosis: a potential role of Nrf2. Antioxid Redox Signal 10:321-332
81. Wei W, Li C, Wang Y, Su H, Zhu J, Kritchevsky D (2003) Hypolipidemic and anti-atherogenic effects of long-term cholestin (Monascus purpureus-fermented rice, red yeast rice) in cholesterol fed rabbits. J Nutr Biochem 14:314-318
82. Wild D, Toth G, Humpf HU (2002) New Monascus metabolite isolated from red yeast rice (angkak, red koji). J Agric Food Chem 50:3999-4002
83. Wu CH, Huang SM, Lin JA, Yen GC (2011) Inhibition of advanced glycation endproduct formation by foodstuffs. Food Funct 2:224-234
84. Yasukawa K, Takahashi M, Natori S, Kawai K, Yamazaki M, Takeuchi M, Takido M (1994) Azaphilones inhibit tumor promotion by 12-O- tetradecanoylphorbol-13-acetate in 2-stage carcinogenesis in mice. Oncology 51:108-112
85. Yasukawa K, Akihisa T, Oinuma H, Kaminaga T, Kanno H, Kasahara Y, Tamura T, Kumaki K, Yamanouchi S, Takido M (1996) Inhibitory effect of taraxastane-type triterpenes on tumor promotion by 12-O-tetradecanoylphorbol-13-acetate in two-stage carcinogenesis in mouse skin. Oncology 53:341-344
86. Yokozawa T, Cho EJ, Park CH, Kim JH (2012) Protective effect of proanthocyanidin against diabetic oxidative stress. Evid Based Complement Alternat Med 2012: Article623879.
87. Zemel MB (2002) Regulation of adiposity and obesity risk by dietary calcium: mechanisms and implications. J Am Coll Nutr 21:146-151
88. Zhong SU, Goldberg IJ, Bruce C, Rubin E, Breslow JL, Tall A (1994) Human apo A-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice. J Clin Invest 94:2457-2467